This announcement is a separate document:
泰達生物：(1) 有關訂立該等協議之關連交易 (2) 修改有關收購SHU JU KU GREATER CHINA, LTD.之 51%股權之主要交易之條款 (3) 有關SJK向香港泰達轉讓SJKGC的39%股權的須予披露交易 (4) 有關訂立補充租賃協議之
TEDA BIOMEDICAL: (1) CONNECTED TRANSACTIONS IN RELATION TO THE ENTERING INTO OF THE AGREEMENTS (2) VARIATION OF TERMS OF MAJOR TRANSACTION IN RELATION TO ACQUISITION OF 51% SHAREHOLDING INTEREST IN SHU JU KU GREATER CHINA, LTD. (3) DISCLOSEABLE TRANSACTIO
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.